Lantern Pharma Raises $3.7 M in Series A Financing

PRESS RELEASE: Today Lantern Pharma Inc. announced the closure of its Series A equity financing of $3.7 million for the biotech company and its clinical-stage cancer treatments. This Series A closing was led by Bios Partners, GPG Ventures and...